M&A
confidence high
sentiment neutral
materiality 0.75
VERU INC. (VERU): M&A transaction — Veru sells ENTADFI assets to Blue Water Vaccines for $20M upfront + up to $80M milestones
VERU INC.
- Asset purchase closed April 19, 2023; buyer paid $6M at closing, owes $4M in FY2023 and $10M in FY2024.
- Potential milestone payments of $10M/$20M/$50M if annual net sales reach $100M/$200M/$500M.
- Buyer assumed 6% royalty on ENTADFI sales and up to $22.5M in milestone obligations from Camargo agreement.
- Veru sold substantially all ENTADFI assets, including IP, regulatory approvals, inventory, and contracts.
- Deal shifts Veru's focus away from ENTADFI; milestone payments uncertain.